Mucosal oncogenic human papillomaviruses and extragenital Bowen disease
✍ Scribed by Christine E. Clavel; Valérie Pham Huu; Anne P. Durlach; Philippe L. Birembaut; Philippe M. Bernard; Christian G. Derancourt
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 130 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
BACKGROUND.
Genital Bowen disease is known to have a strong association with human papillomavirus (HPV) type 16. On the other hand, previous studies of extragenital Bowen disease (EBD) that have used different hybridization techniques have produced discordant results in the detection of mucosal oncogenic HPV.
METHODS.
Ninety-four samples of EBD from 78 patients were investigated clinicopathologically. DNA extracted from fixed and embedded tissues was analyzed for the presence of the main mucosal oncogenic HPV types 16, 18, 31, and 33 using polymerase chain reaction (PCR) with specific primers described in 1996 by Baay et al., which are particularly well adapted to fixed tissues and give small amplimers.
Moreover, 11 EBD of the hands were investigated by in situ hybridization (ISH).
RESULTS.
Of the 94 extragenital BD obtained from 78 patients, HPV DNA type 16 was detected in 78 cases (83%) from 65 patients (83.3%) by PCR. Nine patients with EBD of the hands (90%) had HPV type 16, and ISH displayed a diffuse hybridization pattern that corresponded to the episomal viral form of HPV DNA.
CONCLUSIONS.
The current retrospective study of 94 samples clearly demonstrates the high prevalence of HPV type 16 infection in EBD, especially in EBD of the hands. In this study, no specific clinical, topographic, or histopathologic features of any lesions were found to be indicative of the presence or absence of HPV.
📜 SIMILAR VOLUMES
Papillomavirus in Bowen's Disease of the Hands BACKGROUND. Bowen's disease (BD) of the genital skin region is generally associ-Tsuyoshi Mitsuishi, M
## Abstract Vaccines against high‐risk (hr) human papillomaviruses (HPVs) causing cervical cancer may soon be licensed. Thus, nature of HPV epidemics needs to be studied now. Random sampling for studies on HPV epidemiology was done from all 230,998 women belonging to the population‐based Finnish Ma
## Abstract Oncogenic human papilloma virus (HPV) infection is the most important risk factor for developing cervical cancer. It is known that serum antibody responses against these viruses are associated with persistent infection. We conducted an epidemiological study of 627 women to detect cervic
## Abstract Human papillomavirus (HPV)‐induced carcinogenesis is critically dependent on the activities of the viral __E6__ and __E7__ oncogenes. Here, we demonstrate that expression of the putative tumor suppressor gene __B‐cell translocation gene‐2__ (__BTG2__) is reinduced in HPV16‐ and HPV18‐po